News

Gene Therapy Maker Sarepta Tells Fda It Won't Halt Shipments Despite Patient Deaths
Drugmaker Sarepta Therapeutics said late Friday it will not comply with a request from the Food and Drug Administration to ...
Sarepta’s Risky Gamble: Gene Therapy Stays on Market Despite FDA Request
When three patients die after taking a cutting-edge drug, most companies hit the brakes. Not Sarepta Therapeutics. The ...
Sarepta tells FDA it won’t halt shipments despite patient deaths
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug ...
Sarepta to continue Elevidys shipments despite FDA request to halt
Sarepta (SRPT) plans to continue Elevidys shipments for Duchenne muscular dystrophy, despite FDA request not to do so after ...
TipRanks on MSN22h
JPMorgan, Starbucks, HPE, Sarepta, Elevance: Trending by Analysts
Analysts are intrested in these 5 stocks: ( ($JPM) ), ( ($SBUX) ), ( ($HPE) ), ( ($SRPT) ) and ( ($ELV) ). Here is a breakdown of their recent ...
MoffettNathanson Sticks to Its Buy Rating for Netflix (NFLX)
MoffettNathanson analyst Michael Nathanson maintained a Buy rating on Netflix today and set a price target of $1,400.00. The company’s shares opened today at $1,241.96. Elevate ...
Netflix (NFLX) Gets a Buy from Evercore ISI
Evercore ISI analyst Mark Mahaney maintained a Buy rating on Netflix today and set a price target of $1,375.00. The company’s shares opened today at $1,241.96. Elevate Your Inve ...